Portola Pharmaceuticals Inc is a biopharmaceutical company that develops & commercializes novel therapeutics in the areas of thrombosis other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.


Updates from The Motley Fool

Latest updates on Portola Pharmaceuticals from Fool.com.


Stock Performance

PTLA vs. S&P 500 | 2 Year Performance
View Interactive PTLA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Portola Pharmaceuticals.
Current Price: $25.93
Prev Close: $25.15
Open: $25.25
Bid: $24.32
Ask: $25.93
Day's Range: $25.19 - $25.98
52wk Range: $18.20 - $57.96
Volume: 684,085
Avg Vol 575,653
Market Cap: $1.37B
P/E (ttm): -5.52
EPS (ttm): -$4.56
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Portola Pharmaceuticals.
CAPS Rating 5 out of 5
 
75 Outperform
1 Underperform
CAPS All Stars
 
11 Outperform
1 Underperform

How do you think Portola Pharmaceuticals will perform against the market?



You pick for Portola Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Portola Pharmaceuticals.

Portola Pharmaceuticals Inc is a biopharmaceutical company that develops & commercializes novel therapeutics in the areas of thrombosis other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.

  • Exchange: NASDAQ